Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19
Abstract Background Antithrombotic guidance statements for hospitalized patients with coronavirus disease 2019 (COVID‐19) suggest a universal thromboprophylactic strategy with potential to escalate doses in high‐risk patients. To date, no clear approach exists to discriminate patients at high risk f...
Main Authors: | Alex C. Spyropoulos, Stuart L. Cohen, Eugenia Gianos, Nina Kohn, Dimitrios Giannis, Saurav Chatterjee, Mark Goldin, Marty Lesser, Kevin Coppa, Jamie S. Hirsch, Thomas McGinn, Matthew A. Barish, the COVID‐19 Consortium Group |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-02-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Subjects: | |
Online Access: | https://doi.org/10.1002/rth2.12486 |
Similar Items
-
A review of venous thromboembolism in India
by: Heena Tabassum, et al.
Published: (2023-01-01) -
System-Wide Thromboprophylaxis Interventions for Hospitalized Patients at Risk of Venous Thromboembolism: Focus on Cross-Platform Clinical Decision Support
by: Nikolaos Tsaftaridis, et al.
Published: (2024-04-01) -
Concomitant pulmonary tuberculosis and venous thromboembolism
by: K Gowrinath, et al.
Published: (2023-01-01) -
Prevention and treatment of venous thromboembolism
by: Casadei, B, et al.
Published: (2020) -
The Risk of Venous Thromboembolism in Neuroendocrine Neoplasms
by: Monika Wójcik-Giertuga, et al.
Published: (2023-11-01)